NASDAQ:EYE National Vision (EYE) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free EYE Stock Alerts $17.88 +0.01 (+0.06%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$17.69▼$18.2950-Day Range$17.73▼$23.8152-Week Range$13.71▼$27.02Volume636,782 shsAverage Volume963,626 shsMarket Capitalization$1.40 billionP/E RatioN/ADividend YieldN/APrice Target$23.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get National Vision alerts: Email Address National Vision MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside33.4% Upside$23.86 Price TargetShort InterestHealthy10.18% of Float Sold ShortDividend StrengthN/ASustainability-1.35Upright™ Environmental ScoreNews Sentiment0.32Based on 10 Articles This WeekInsider TradingN/AProj. Earnings Growth51.61%From $0.31 to $0.47 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.74 out of 5 starsMedical Sector211th out of 913 stocksOphthalmic Goods Industry2nd out of 6 stocks 3.0 Analyst's Opinion Consensus RatingNational Vision has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageNational Vision has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted10.18% of the float of National Vision has been sold short.Short Interest Ratio / Days to CoverNational Vision has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in National Vision has recently decreased by 10.73%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNational Vision does not currently pay a dividend.Dividend GrowthNational Vision does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNational Vision has received a 37.34% net impact score from Upright. National Vision seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Private optician services", "Physical retail of eyeglasses at an optician store", and "Physical retail of contact lenses at an optician store" products. See details.Environmental SustainabilityThe Environmental Impact score for National Vision is -1.35. Previous Next 1.8 News and Social Media Coverage News SentimentNational Vision has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for National Vision this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for EYE on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added National Vision to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Vision insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.10% of the stock of National Vision is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for National Vision are expected to grow by 51.61% in the coming year, from $0.31 to $0.47 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Vision is -21.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of National Vision is -21.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioNational Vision has a PEG Ratio of 3.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioNational Vision has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About National Vision Stock (NASDAQ:EYE)National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Read More EYE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EYE Stock News HeadlinesApril 27, 2024 | americanbankingnews.comNational Vision Holdings, Inc. (NASDAQ:EYE) Receives Average Recommendation of "Hold" from AnalystsApril 26, 2024 | msn.comSuperbug from human eye drops outbreak spread to dogsApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 26, 2024 | msn.comArizonan named to USA Blind Soccer Men's National TeamApril 24, 2024 | msn.comLong hours on screens linked to vision problems, Oireachtas Committee toldApril 24, 2024 | msn.comArizona athlete named to USA Blind Soccer Men's National TeamApril 24, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$1.39m On National Vision HoldingsApril 24, 2024 | businesswire.comNational Vision Holdings, Inc. Announces First Quarter 2024 Earnings Release and Conference CallApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 23, 2024 | tmcnet.comOld Dominion University, HaptX, and Georgia Tech Win Grant Award for Project to Advance VR for Vision-ImpairedApril 20, 2024 | nytimes.comTime Is Running Out for Rahul Gandhi’s Vision for IndiaApril 11, 2024 | msn.comPH, US, Japan eye more combined naval training and exercisesApril 11, 2024 | msn.comDriving at night can get harder starting as early as your late 20s. Here’s how to improve nighttime vision.April 11, 2024 | msn.comEye injuries surge following solar eclipse: ‘Damage can be irreversible’April 10, 2024 | businessinsider.comIf your eyes hurt after watching the solar eclipse, here's what you need to knowApril 9, 2024 | msn.comSymptoms of eye damage from looking at a solar eclipse might not appear for hoursApril 8, 2024 | msn.comDid you look at the solar eclipse too long? Doctors explain signs of eye damageApril 8, 2024 | msn.comNew Jersey’s 39 best empanadas, for National Empanada Day 2024April 7, 2024 | msn.comEclipse eye safety: How to safely see Monday's eclipseApril 4, 2024 | msn.com'I thought my eye would fall out of my head'April 4, 2024 | msn.comNoem banned from South Dakota ReservationApril 3, 2024 | msn.comMan with 'protruding' eye 'went to hospital nine times' before diagnosisApril 2, 2024 | bizjournals.com8 things to know: Pratt Library up for national awardMarch 28, 2024 | msn.com3 Worcester high school students national award for app that helps the visually impairedMarch 28, 2024 | finance.yahoo.comNational Vision (EYE) Down 4.1% Since Last Earnings Report: Can It Rebound?March 21, 2024 | msn.comWaco eye expert highlights importance of solar eclipse glassesMarch 20, 2024 | yahoo.comEye Docs’ Top Tips to Get Rid of a Stye Fast — Plus the One Thing You Should Never DoSee More Headlines Receive EYE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today4/26/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Ophthalmic goods Sub-IndustryN/A Current SymbolNASDAQ:EYE Previous SymbolNYSE:EYE CUSIPN/A CIK1710155 Webwww.nationalvision.com Phone(770) 822-3600FaxN/AEmployees13,998Year FoundedN/APrice Target and Rating Average Stock Price Target$23.86 High Stock Price Target$34.00 Low Stock Price Target$19.00 Potential Upside/Downside+33.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.85) Trailing P/E RatioN/A Forward P/E Ratio57.68 P/E Growth3.99Net Income$-65,900,000.00 Net Margins-3.10% Pretax Margin-2.90% Return on Equity3.69% Return on Assets1.41% Debt Debt-to-Equity Ratio0.54 Current Ratio1.00 Quick Ratio0.70 Sales & Book Value Annual Sales$2.13 billion Price / Sales0.66 Cash Flow$1.78 per share Price / Cash Flow10.07 Book Value$10.60 per share Price / Book1.69Miscellaneous Outstanding Shares78,310,000Free Float76,668,000Market Cap$1.40 billion OptionableOptionable Beta1.39 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. L. Reade Fahs (Age 63)CEO, President & Director Comp: $1.02MMr. Patrick R. Moore (Age 60)Senior VP & COO Comp: $630.1kMr. Jared Brandman (Age 47)Senior VP, General Counsel & Secretary Comp: $402.21kMr. Joe VanDette (Age 46)Senior VP & Chief Marketing Officer Comp: $442.08kMr. Bill Clark (Age 49)Senior VP & Chief People Officer Comp: $382.37kMs. Melissa Rasmussen (Age 47)Senior VP & CFO Comp: $208.05kMr. Ravi Acharya (Age 49)Chief Technology Officer & Senior VP David Mann C.F.A.Senior Vice President of Investor RelationsMs. Jacqueline GroveSenior VP of Talent, Development, Culture, Diversity, Equity & Inclusion and PhilanthropyMr. Paul Myrick (Age 59)Senior Vice President of Real Estate More ExecutivesKey CompetitorsWarby ParkerNYSE:WRBYRxSightNASDAQ:RXSTSTAAR SurgicalNASDAQ:STAABausch + LombNYSE:BLCOArdelyxNASDAQ:ARDXView All CompetitorsInsiders & InstitutionsYousif Capital Management LLCSold 3,570 shares on 4/26/2024Ownership: 0.045%New York State Teachers Retirement SystemSold 1,600 shares on 4/25/2024Ownership: 0.024%Allspring Global Investments Holdings LLCSold 120,655 shares on 4/18/2024Ownership: 0.527%PNC Financial Services Group Inc.Bought 2,400 shares on 3/22/2024Ownership: 0.009%HBK Investments L PSold 30,000 shares on 3/14/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions EYE Stock Analysis - Frequently Asked Questions Should I buy or sell National Vision stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EYE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EYE, but not buy additional shares or sell existing shares. View EYE analyst ratings or view top-rated stocks. What is National Vision's stock price target for 2024? 5 analysts have issued 1-year price targets for National Vision's stock. Their EYE share price targets range from $19.00 to $34.00. On average, they predict the company's stock price to reach $23.86 in the next twelve months. This suggests a possible upside of 33.4% from the stock's current price. View analysts price targets for EYE or view top-rated stocks among Wall Street analysts. How have EYE shares performed in 2024? National Vision's stock was trading at $20.93 at the beginning of the year. Since then, EYE stock has decreased by 14.6% and is now trading at $17.88. View the best growth stocks for 2024 here. Are investors shorting National Vision? National Vision saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 7,820,000 shares, a drop of 10.7% from the March 31st total of 8,760,000 shares. Based on an average trading volume of 987,100 shares, the days-to-cover ratio is currently 7.9 days. Currently, 10.2% of the shares of the company are short sold. View National Vision's Short Interest. When is National Vision's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our EYE earnings forecast. How can I listen to National Vision's earnings call? National Vision will be holding an earnings conference call on Wednesday, May 8th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were National Vision's earnings last quarter? National Vision Holdings, Inc. (NASDAQ:EYE) announced its earnings results on Tuesday, February, 27th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $0.07. The firm had revenue of $506.40 million for the quarter, compared to analysts' expectations of $499.49 million. National Vision had a negative net margin of 3.10% and a positive trailing twelve-month return on equity of 3.69%. National Vision's quarterly revenue was up 8.0% on a year-over-year basis. During the same period last year, the business earned ($0.11) EPS. What ETFs hold National Vision's stock? ETFs with the largest weight of National Vision (NASDAQ:EYE) stock in their portfolio include Invesco S&P SmallCap Consumer Discretionary ETF (PSCD).SPDR S&P 600 Small Cap ETF (SLY). What guidance has National Vision issued on next quarter's earnings? National Vision issued an update on its FY24 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of $0.50-$0.65 for the period, compared to the consensus EPS estimate of $0.56. The company issued revenue guidance of $1.965-$2.005 billion, compared to the consensus revenue estimate of $1.94 billion. What is L. Reade Fahs' approval rating as National Vision's CEO? 243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of National Vision own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Vision investors own include Verizon Communications (VZ), Enterprise Products Partners (EPD), AT&T (T), Carnival Co. & (CCL), Antares Pharma (ATRS), Advanced Micro Devices (AMD), Gilead Sciences (GILD), QUALCOMM (QCOM), Tanger (SKT) and STMicroelectronics (STM). When did National Vision IPO? National Vision (EYE) raised $300 million in an initial public offering on Thursday, October 26th 2017. The company issued 15,800,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers. Who are National Vision's major shareholders? National Vision's stock is owned by many different institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.53%), Yousif Capital Management LLC (0.04%) and New York State Teachers Retirement System (0.02%). Insiders that own company stock include D Randolph Peeler, Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Ravi Acharya and Virginia A Hepner. View institutional ownership trends. How do I buy shares of National Vision? Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:EYE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
